Therefore, our results suggest that strong Tiam1 overexpression is a new and independent predictor of disease recurrence for patients with prostate cancer and that tumours with strong Tiam1 overexpression require more aggressive treatment. This evidence concerns the gene TIAM1 and neoplasm.